| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/14/2008 | EP1653934B1 Use of c-kit inhibitors for treating type ii diabetes |
| 05/14/2008 | EP1648566B1 Method for the production of flavonoid-containing compositions and use thereof |
| 05/14/2008 | EP1635833B1 Combination of opioids and a piperazine derivative for the treatment of pain |
| 05/14/2008 | EP1622584B1 Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid |
| 05/14/2008 | EP1606277B1 Imidazol-4-yl-ethynyl-pyridine derivatives |
| 05/14/2008 | EP1601361B1 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 05/14/2008 | EP1553943B1 Use of tenatoprazole for the treatment of gastroesophageal reflux |
| 05/14/2008 | EP1531790A4 Cosmetic composition structured with silicone polymers and film-forming resins |
| 05/14/2008 | EP1513525B1 Use of mglur5 antagonists for the treatment of gerd |
| 05/14/2008 | EP1506009B1 Beta-glucan-based anti-fungal vaccines |
| 05/14/2008 | EP1496875B1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | EP1470103B1 Amidoacetonitrile derivatives |
| 05/14/2008 | EP1465900B1 Rho-kinase inhibitors |
| 05/14/2008 | EP1461049B1 Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 05/14/2008 | EP1453531B1 Use of hmgb proteins and nucleic acids that code therefor |
| 05/14/2008 | EP1446375B1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents |
| 05/14/2008 | EP1429789B1 Anti-infectious carbohydrates |
| 05/14/2008 | EP1427748B1 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds |
| 05/14/2008 | EP1355636B1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 05/14/2008 | EP1305031B1 Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents |
| 05/14/2008 | EP1300158B1 Pharmaceutical compositions for angiogenic therapy |
| 05/14/2008 | EP1278540B1 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/14/2008 | EP1274429B1 Topical formulations for the transdermal delivery of niacin prodrugs and methods of treating hyperlipidemia |
| 05/14/2008 | EP1267867B1 Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists |
| 05/14/2008 | EP1264821B1 Novel crystal of stilbene derivative and process for producing the same |
| 05/14/2008 | EP1250455B1 Antisense inhibition of ptp1b expression |
| 05/14/2008 | EP1248600B1 Improved hiv protease inhibitors pharmaceutical formulations |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | EP1171159B1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 05/14/2008 | EP1021148B1 Composition and method for acceleration of wound and burn healing |
| 05/14/2008 | EP1017418B1 Vaccine composition for preventing or treating c hepatitis |
| 05/14/2008 | EP0840749B1 The h-y antigen |
| 05/14/2008 | EP0811075B1 A method for the isolation and purification of lipid cell-wall components |
| 05/14/2008 | EP0772437B9 Compositions for delivery of genetic material |
| 05/14/2008 | EP0755402B1 Alpha(1,3) galactosyltransferase negative swine |
| 05/14/2008 | CN101180319A Aldehyde conjugated flavonoid preparations |
| 05/14/2008 | CN101180300A New isothiazoloquinolones and related compounds as anti-infective agents |
| 05/14/2008 | CN101180299A Acetylenyl-pyrazolo-pvrimidine derivatives as MGLUR2 antagonists |
| 05/14/2008 | CN101180298A New antibiotic derivatives |
| 05/14/2008 | CN101180297A Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
| 05/14/2008 | CN101180296A Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors |
| 05/14/2008 | CN101180292A 2-azetidinyl-4-(lH-pyrazol-3-ylamino)pyrimidines as inhibitors of insulin-like growth factor-i receptor activity |
| 05/14/2008 | CN101180291A Benzimidazole-carboxamide compounds as 5-ht4, receptor agonists |
| 05/14/2008 | CN101180290A Hydogrenated benzo[c] thiophene derivatives as immunomodulators |
| 05/14/2008 | CN101180288A Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs |
| 05/14/2008 | CN101180283A Dihydrobenzofuran derivatives and uses thereof |
| 05/14/2008 | CN101180280A 1,2,4-triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors |
| 05/14/2008 | CN101180278A 2-amino-4-phenylquinazoline derivates and their use as HSP90 modulators |
| 05/14/2008 | CN101180276A 2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 05/14/2008 | CN101180275A Pyridine, and pyridazine derivatives |
| 05/14/2008 | CN101180271A Process for producing carbapenem derivative having a 1-alkylpyrrolidine structure |
| 05/14/2008 | CN101180270A Novel trifluoromethoxy-substituted aryl anilides |
| 05/14/2008 | CN101180268A Novel haloalkoxy-substituted salicylic anilides |
| 05/14/2008 | CN101180267A Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 05/14/2008 | CN101180264A Benzoic acid ester compounds, compositions, uses and methods related thereto |
| 05/14/2008 | CN101180260A Organic compounds |
| 05/14/2008 | CN101180097A Novel phosphinic acid-containing thyromimetics |
| 05/14/2008 | CN101180096A Method and composition for treating mucosal disorders |
| 05/14/2008 | CN101180080A Nutritive composition including green tea polyphenol for treating osteosarcoma |
| 05/14/2008 | CN101180073A Insulins combinations |
| 05/14/2008 | CN101180072A Methods of using death receptor agonists and egfr inhibitors |
| 05/14/2008 | CN101180071A Composition for enzyme inhibition |
| 05/14/2008 | CN101180066A New uses of dinucleotide polyphosphate derivatives |
| 05/14/2008 | CN101180065A A composition containing timosaponin A-III for prevention and treatment of type 2 diabetes mellitus |
| 05/14/2008 | CN101180064A Solid pharmaceutical composition with telithromycin |
| 05/14/2008 | CN101180063A Phospholipids for use in the treatment of an allergic inflammatory condition |
| 05/14/2008 | CN101180061A Compounds, and compositions containing the compounds, and method for treatment of metastatic melanoma and other cancers |
| 05/14/2008 | CN101180060A Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases |
| 05/14/2008 | CN101180059A Combination of indacaterol derivates for curing air flue disease and other matters |
| 05/14/2008 | CN101180058A Indacterol derivatives and phosphodiesterase inhibitors for the treatment of airway diseases |
| 05/14/2008 | CN101180057A Piperidinyl substituted cyclohexane-1,4-diamines |
| 05/14/2008 | CN101180056A Agent for treating involuntary movement |
| 05/14/2008 | CN101180055A Combination therapy comprising diaryl ureas for treating diseases |
| 05/14/2008 | CN101180054A Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 05/14/2008 | CN101180053A Treatment of liver diseases in which iron plays a role in pathogenesis |
| 05/14/2008 | CN101180052A Film coated preparation containing dextrose |
| 05/14/2008 | CN101180051A Method for preparation of aqueous doripenem solution |
| 05/14/2008 | CN101180050A Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 05/14/2008 | CN101180049A Nutritive composition for treating sarcoma and prostate cancer |
| 05/14/2008 | CN101180048A Amino acid composition for improving glucose tolerance |
| 05/14/2008 | CN101180047A Use of cyclodextrin complexes containing lipoic acid |
| 05/14/2008 | CN101180046A Stable tablet containing droxidopa |
| 05/14/2008 | CN101180045A Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands |
| 05/14/2008 | CN101180044A Combination of egf/ghrp-6 for neuroregeneration of central nervous system |
| 05/14/2008 | CN101180043A Versatile high load concentrate compositions for control of ecto-parasites |
| 05/14/2008 | CN101180041A Therapeutic agent for sensory abnormality |
| 05/14/2008 | CN101180038A Nanoparticulate corticosteroid and antihistamine formulations |
| 05/14/2008 | CN101180036A Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
| 05/14/2008 | CN101180033A Methods of treating skin and mucosal tissue atrophy using compositions including tensioning polymers |
| 05/14/2008 | CN101180028A Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne |
| 05/14/2008 | CN101179954A Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses |
| 05/14/2008 | CN101179937A Gel compositions for control of ecto-parasites |
| 05/14/2008 | CN101177445A Novel bufadienolide compound as well as preparation method and uses thereof |
| 05/14/2008 | CN101177438A N-acetylglucosamine derivatives and use thereof |
| 05/14/2008 | CN101177435A Cyanidenon ammino platinum anti-cancer drugs and method for making same |
| 05/14/2008 | CN101177434A Meletin ammino platinum anti-cancer drugs and method for making same |